Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-003382

Chief Financial Officer acquired 58,601 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NOUGUES MAXIMO F Chief Financial Officer 2023-02-10 Grant or award +58,601 159,028 D
Derivatives
NOUGUES MAXIMO F Chief Financial Officer 2023-02-10 Grant or award · Stock Option (Right to Buy) +81,399 81,399 D
Loading xslF345X03/rdgdoc.xml…